Developmental role of macrophage cannabinoid-1 receptor signaling in type 2 diabetes

Tony Jourdan, G. Szanda, Resat Cinar, Grzegorz Godlewski, David J. Holovac, Joshua K. Park, Sarah Nicoloro, Yuefei Shen, Jie Liu, Avi Z. Rosenberg, Ziyi Liu, Michael P. Czech, George Kunos

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Islet inflammation promotes β-cell loss and type 2 diabetes (T2D), a process replicated in Zucker Diabetic Fatty (ZDF) rats in which β-cell loss has been linked to cannabinoid-1 receptor (CB1R)-induced proinflammatory signaling in macrophages infiltrating pancreatic islets. Here, we analyzed CB1R signaling in macrophages and its developmental role in T2D. ZDF rats with global deletion of CB1R are protected from β-cell loss, hyperglycemia, and nephropathy that are present in ZDF littermates. Adoptive transfer of CB1R-/- bone marrow to ZDF rats also prevents β-cell loss and hyperglycemia but not nephropathy. ZDF islets contain elevated levels of CB1R, interleukin-1b, tumor necrosis factor-A, the chemokine CCL2, and interferon regulatory factor-5 (IRF5), a marker of inflammatory macrophage polarization. In primary cultured rodent and human macrophages, CB1R activation increased Irf5 expression, whereas knockdown of Irf5 blunted CB1R-induced secretion of inflammatory cytokines without affecting CCL2 expression, which was p38MAPKa dependent. Macrophage-specific in vivo knockdown of Irf5 protected ZDF rats from β-cell loss and hyperglycemia. Thus, IRF5 is a crucial downstream mediator of diabetogenic CB1R signaling in macrophages and a potential therapeutic target.

Original languageEnglish
Pages (from-to)994-1007
Number of pages14
JournalDiabetes
Volume66
Issue number4
DOIs
Publication statusPublished - Apr 1 2017

Fingerprint

Cannabinoid Receptors
Type 2 Diabetes Mellitus
Macrophages
Interferon Regulatory Factors
Hyperglycemia
Adoptive Transfer
Chemokine CCL2
Interleukin-1
Islets of Langerhans
Rodentia
Tumor Necrosis Factor-alpha
Bone Marrow
Cytokines
Inflammation

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Jourdan, T., Szanda, G., Cinar, R., Godlewski, G., Holovac, D. J., Park, J. K., ... Kunos, G. (2017). Developmental role of macrophage cannabinoid-1 receptor signaling in type 2 diabetes. Diabetes, 66(4), 994-1007. https://doi.org/10.2337/db16-1199

Developmental role of macrophage cannabinoid-1 receptor signaling in type 2 diabetes. / Jourdan, Tony; Szanda, G.; Cinar, Resat; Godlewski, Grzegorz; Holovac, David J.; Park, Joshua K.; Nicoloro, Sarah; Shen, Yuefei; Liu, Jie; Rosenberg, Avi Z.; Liu, Ziyi; Czech, Michael P.; Kunos, George.

In: Diabetes, Vol. 66, No. 4, 01.04.2017, p. 994-1007.

Research output: Contribution to journalArticle

Jourdan, T, Szanda, G, Cinar, R, Godlewski, G, Holovac, DJ, Park, JK, Nicoloro, S, Shen, Y, Liu, J, Rosenberg, AZ, Liu, Z, Czech, MP & Kunos, G 2017, 'Developmental role of macrophage cannabinoid-1 receptor signaling in type 2 diabetes', Diabetes, vol. 66, no. 4, pp. 994-1007. https://doi.org/10.2337/db16-1199
Jourdan T, Szanda G, Cinar R, Godlewski G, Holovac DJ, Park JK et al. Developmental role of macrophage cannabinoid-1 receptor signaling in type 2 diabetes. Diabetes. 2017 Apr 1;66(4):994-1007. https://doi.org/10.2337/db16-1199
Jourdan, Tony ; Szanda, G. ; Cinar, Resat ; Godlewski, Grzegorz ; Holovac, David J. ; Park, Joshua K. ; Nicoloro, Sarah ; Shen, Yuefei ; Liu, Jie ; Rosenberg, Avi Z. ; Liu, Ziyi ; Czech, Michael P. ; Kunos, George. / Developmental role of macrophage cannabinoid-1 receptor signaling in type 2 diabetes. In: Diabetes. 2017 ; Vol. 66, No. 4. pp. 994-1007.
@article{9db16252baa84e89b0cfaf51f8ba670d,
title = "Developmental role of macrophage cannabinoid-1 receptor signaling in type 2 diabetes",
abstract = "Islet inflammation promotes β-cell loss and type 2 diabetes (T2D), a process replicated in Zucker Diabetic Fatty (ZDF) rats in which β-cell loss has been linked to cannabinoid-1 receptor (CB1R)-induced proinflammatory signaling in macrophages infiltrating pancreatic islets. Here, we analyzed CB1R signaling in macrophages and its developmental role in T2D. ZDF rats with global deletion of CB1R are protected from β-cell loss, hyperglycemia, and nephropathy that are present in ZDF littermates. Adoptive transfer of CB1R-/- bone marrow to ZDF rats also prevents β-cell loss and hyperglycemia but not nephropathy. ZDF islets contain elevated levels of CB1R, interleukin-1b, tumor necrosis factor-A, the chemokine CCL2, and interferon regulatory factor-5 (IRF5), a marker of inflammatory macrophage polarization. In primary cultured rodent and human macrophages, CB1R activation increased Irf5 expression, whereas knockdown of Irf5 blunted CB1R-induced secretion of inflammatory cytokines without affecting CCL2 expression, which was p38MAPKa dependent. Macrophage-specific in vivo knockdown of Irf5 protected ZDF rats from β-cell loss and hyperglycemia. Thus, IRF5 is a crucial downstream mediator of diabetogenic CB1R signaling in macrophages and a potential therapeutic target.",
author = "Tony Jourdan and G. Szanda and Resat Cinar and Grzegorz Godlewski and Holovac, {David J.} and Park, {Joshua K.} and Sarah Nicoloro and Yuefei Shen and Jie Liu and Rosenberg, {Avi Z.} and Ziyi Liu and Czech, {Michael P.} and George Kunos",
year = "2017",
month = "4",
day = "1",
doi = "10.2337/db16-1199",
language = "English",
volume = "66",
pages = "994--1007",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "4",

}

TY - JOUR

T1 - Developmental role of macrophage cannabinoid-1 receptor signaling in type 2 diabetes

AU - Jourdan, Tony

AU - Szanda, G.

AU - Cinar, Resat

AU - Godlewski, Grzegorz

AU - Holovac, David J.

AU - Park, Joshua K.

AU - Nicoloro, Sarah

AU - Shen, Yuefei

AU - Liu, Jie

AU - Rosenberg, Avi Z.

AU - Liu, Ziyi

AU - Czech, Michael P.

AU - Kunos, George

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Islet inflammation promotes β-cell loss and type 2 diabetes (T2D), a process replicated in Zucker Diabetic Fatty (ZDF) rats in which β-cell loss has been linked to cannabinoid-1 receptor (CB1R)-induced proinflammatory signaling in macrophages infiltrating pancreatic islets. Here, we analyzed CB1R signaling in macrophages and its developmental role in T2D. ZDF rats with global deletion of CB1R are protected from β-cell loss, hyperglycemia, and nephropathy that are present in ZDF littermates. Adoptive transfer of CB1R-/- bone marrow to ZDF rats also prevents β-cell loss and hyperglycemia but not nephropathy. ZDF islets contain elevated levels of CB1R, interleukin-1b, tumor necrosis factor-A, the chemokine CCL2, and interferon regulatory factor-5 (IRF5), a marker of inflammatory macrophage polarization. In primary cultured rodent and human macrophages, CB1R activation increased Irf5 expression, whereas knockdown of Irf5 blunted CB1R-induced secretion of inflammatory cytokines without affecting CCL2 expression, which was p38MAPKa dependent. Macrophage-specific in vivo knockdown of Irf5 protected ZDF rats from β-cell loss and hyperglycemia. Thus, IRF5 is a crucial downstream mediator of diabetogenic CB1R signaling in macrophages and a potential therapeutic target.

AB - Islet inflammation promotes β-cell loss and type 2 diabetes (T2D), a process replicated in Zucker Diabetic Fatty (ZDF) rats in which β-cell loss has been linked to cannabinoid-1 receptor (CB1R)-induced proinflammatory signaling in macrophages infiltrating pancreatic islets. Here, we analyzed CB1R signaling in macrophages and its developmental role in T2D. ZDF rats with global deletion of CB1R are protected from β-cell loss, hyperglycemia, and nephropathy that are present in ZDF littermates. Adoptive transfer of CB1R-/- bone marrow to ZDF rats also prevents β-cell loss and hyperglycemia but not nephropathy. ZDF islets contain elevated levels of CB1R, interleukin-1b, tumor necrosis factor-A, the chemokine CCL2, and interferon regulatory factor-5 (IRF5), a marker of inflammatory macrophage polarization. In primary cultured rodent and human macrophages, CB1R activation increased Irf5 expression, whereas knockdown of Irf5 blunted CB1R-induced secretion of inflammatory cytokines without affecting CCL2 expression, which was p38MAPKa dependent. Macrophage-specific in vivo knockdown of Irf5 protected ZDF rats from β-cell loss and hyperglycemia. Thus, IRF5 is a crucial downstream mediator of diabetogenic CB1R signaling in macrophages and a potential therapeutic target.

UR - http://www.scopus.com/inward/record.url?scp=85019608681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019608681&partnerID=8YFLogxK

U2 - 10.2337/db16-1199

DO - 10.2337/db16-1199

M3 - Article

C2 - 28082458

AN - SCOPUS:85019608681

VL - 66

SP - 994

EP - 1007

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 4

ER -